BRITANNIA LIFE SCIENCES

Research BRITANNIA LIFE SCIENCES (L020) on Bullrun: market cap EUR 6.67M, P/E 0.5. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerL020
ExchangeF
CountryCanada
SectorHealthcare
IndustryBiotechnology
CurrencyEUR
Market capEUR 6.67M
P/E0.5
Financial periodFY2025
Revenue-CAD 4.33M
Net incomeCAD 20.49M
Free cash flow-CAD 3.82M
Gross margin68.8%

Valuation Snapshot

latest market cap is EUR 6.67M; P/E is 0.5.

Peer valuation comparison

Latest P/E is 0.48x versus a Healthcare sector median of 24.46x (98.0% below).

Latest P/E is 0.48x versus a Canada median of 15.58x (96.9% below).

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	-CAD 4.33M	CAD 20.49M	-CAD 3.82M	68.8%	n/a	CAD 1.82M	CAD 248.56K	CAD 17.23M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-23	EUR 6.67M	0.5	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About BRITANNIA LIFE SCIENCES

Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. The company serves cosmetics, consumer packaged and household goods, and nutraceutical industries. Britannia Life Sciences Inc. is headquartered in Toronto, Canada.

Related stock research

Canada stocks Canada Healthcare stocks A-Z stock index

Other Healthcare stocks

Entheon Biomedical Corp. (1XU) NANOSPHERE HEA.SCIENCES (2CG) MedMira Inc (47M) BRAXIA SCIENTIFIC CORP. (4960) WAVERLEY PHARMA INC. (5GZ) BioVaxys Technology Corp. (5LB0) GLOW LIFETECH CORP. (9DO) NERVGEN PHARMA CORP. (9UA) AbCellera Biologics Inc (ABCL) Appili Therapeutics Inc (APLI) Arch Biopartners Inc (ARCH) Aurinia Pharmaceuticals Inc (AUPH)